Health In Tech Q1 revenue up 9.4% to $8.8M; net loss of $1.6M vs prior year profit

Health In Tech, Inc.

Revenue $8.8M (+9.4% YoY); net loss $1.6M ($0.03 diluted loss) vs net income $0.5M in Q1 2025.
Adjusted EBITDA -$1.3M vs +$1.2M; higher sales/marketing spending for growth initiatives.
Reiterated FY 2026 revenue guidance $45M-$50M (35-50% YoY growth); contracted revenue for rest of year $22.9M.
Distribution partners up 29.5% YoY to 896; cash $10.3M, working capital $15.0M.
Completed ~$7M PIPE in March; proceeds to fund sales expansion, new marketplace offerings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.